ストックスクリーナーアプリを入手
72.09
0.32%
0.23
プレマーケット:
71.99
-0.10
-0.14%
前日終値:
$71.86
開ける：
$71.94
24時間の取引高:
735.32K
Relative Volume:
0.80
時価総額：
$12.47B
収益：
$8.31B
当期純損益:
$379.00M
株価収益率:
33.38
EPS:
2.16
ネットキャッシュフロー:
$385.00M
1週間 パフォーマンス:
-0.47%
1か月 パフォーマンス:
-2.32%
6か月 パフォーマンス:
-2.16%
1年 パフォーマンス:
+24.92%
1日の値動き範囲:
$71.34
$72.40
1週間の範囲:
$71.34
$74.98
52週間の値動き範囲:
$56.69
$85.92
Solventum Corp Stock (SOLV) Company Profile
SOLV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
72.09 | 12.46B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
478.19 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
194.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.03 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
283.29 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
239.90 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | アップグレード | Argus | Hold → Buy |
| 2025-06-06 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-10-08 | 開始されました | Stifel | Buy |
| 2024-10-07 | 開始されました | Piper Sandler | Neutral |
| 2024-09-26 | 開始されました | Wolfe Research | Peer Perform |
| 2024-09-05 | 開始されました | BTIG Research | Neutral |
| 2024-06-24 | 開始されました | Argus | Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2024-05-10 | 開始されました | BofA Securities | Neutral |
| 2024-04-10 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 開始されました | Wells Fargo | Equal Weight |
| 2024-04-02 | 開始されました | Edward Jones | Hold |
すべてを表示
Solventum Corp (SOLV) 最新ニュース
Solventum Corporation (SOLV) Reports Q2 2025 Results; Mizuho and Wells Fargo Reiterate Their Ratings - ca.finance.yahoo.com
Solventum ups financial guidance as tariff risks fade - MSN
How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks? - MSN
Will Strong Q2 Results and Raised Outlook Change Solventum's (SOLV) Narrative? - simplywall.st
Solventum raises annual profit forecast on strength in surgical equipment - MSN
Piper Sandler Boosts Solventum (NYSE:SOLV) Price Target to $94.00 - MarketBeat
Should Solventum's (SOLV) Earnings Upgrade and Revenue Growth Prompt Portfolio Reassessment by Investors? - simplywall.st
Solventum 2025 Q2 Earnings Net Income Rises 1.1% - AInvest
Stock Analysis | Solventum OutlookNavigating Mixed Signals Amid Weak Technicals - AInvest
Solventum Q2 FY25 slides reveal improved performance and increased full-year outlook - Investing.com Canada
Solventum Exceeds 2Q25 Expectations with $2.16B Revenue, Reduces Tariff Impact - Medical Device and Diagnostic industry
Goldman Sachs Adjusts Solventum Price Target to $73 From $71, Maintains Sell Rating - MarketScreener
Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve - The Globe and Mail
Solventum Stock Gains On Q2 Earnings & Revenue Beat, Margins Improve - Barchart.com
Solventum raises 2025 EPS guidance to $5.80-$5.95 with sales growth outlook up to 3% as transformation gains momentum - MSN
Solventum Boosts Annual Profit Outlook on Surging Medical Device DemandNews and Statistics - IndexBox
Solventum stock price target raised to $94 by Piper Sandler on strong Q2 - Investing.com Nigeria
Solventum price target raised to $94 from $87 at Piper Sandler - TipRanks
Solventum rises after lifting annual profit forecast - TradingView
Solventum Raises EPS Guidance to $5.80-$5.95, Sales Growth Outlook Up to 3% Amid Transformation Gains - AInvest
Earnings call transcript: Solventum’s Q2 2025 earnings beat expectations - Investing.com
Earnings call transcript: Solventum’s Q2 2025 earnings beat expectations By Investing.com - Investing.com UK
Solventum: Q2 Earnings Snapshot - Connecticut Post
Morgan Stanley Upgrades Solventum (SOLV) on Growth Potential - MSN
Solventum Corp SEC 10-Q Report - TradingView
Solventum Q2 FY25 slides reveal improved performance and increased full-year outlook By Investing.com - Investing.com South Africa
Solventum 2025 Q2 Earnings Positive Earnings Growth with Raised Guidance - AInvest
Solventum (SOLV) Fiscal Q2 EPS Jumps 8% - AOL.com
Solventum Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Solventum (SOLV) Q2 2025 Earnings Call Transcript - Fortune
Solventum (SOLV) Reports Earnings Tomorrow: What To Expect - MSN
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Solventum shares surge as raised guidance tops expectations By Investing.com - Investing.com South Africa
Solventum shares surge as raised guidance tops expectations - Investing.com
Solventum reports Q2 adjusted EPS $1.69, consensus $1.45 - TipRanks
Solventum raises annual profit forecast on strength in surgical equipment By Reuters - Investing.com
Solventum Corporation Q2 Sales Increase - Nasdaq
Solventum beats The Street in Q2, raises full-year guidance - MassDevice
Solventum Q2 sales up 3.9% YoY, raises FY23 EPS outlook to $5.80-$5.95. - AInvest
Solventum’s (NYSE:SOLV) Q2: Beats On Revenue - Yahoo Finance
Earnings Flash (SOLV) Solventum Corporation Reports Q2 Revenue $2.16B, vs. FactSet Est of $2.12B - MarketScreener
Earnings Flash (SOLV) Solventum Corporation Posts Q2 Adjusted EPS $1.69 per Share, vs. FactSet Est of $1.45 - MarketScreener
Solventum Reports Second Quarter 2025 Financial Results - PR Newswire
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings? - MSN
Ahead of Solventum (SOLV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics - MSN
Industry Insider: After 3M Separation, Solventum Targets Digital Integration in Ortho - Orthodontic Products
Solventum Corp (SOLV) 財務データ
収益
当期純利益
現金流量
EPS
Solventum Corp (SOLV) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hanson Bryan C | Chief Executive Officer |
May 13 '25 |
Option Exercise |
0.00 |
34,315 |
0 |
75,108 |
| Harris Bernard A Jr | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Edwards Shirley Ann | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '25 |
Option Exercise |
0.00 |
2,375 |
0 |
2,375 |
| DeVore Susan D. | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| ALBAN CARLOS | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '25 |
Option Exercise |
0.00 |
3,959 |
0 |
11,220 |
| Wendell Amy McBride | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| MAY KAREN J | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Mily Elizabeth | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,626 |
2.22%
0.06%
大文字化:
|
ボリューム (24 時間):